18
Unit of Gastrenterology Unit of Endocrinology THEAGENIO Hospital, Thessaloniki static neuroendocrine tumor of the jejunum-i

Unit of Gastrenterology Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Embed Size (px)

DESCRIPTION

Metastatic neuroendocrine tumor of the jejunum-ileum. Unit of Gastrenterology Unit of Endocrinology THEAGENIO Hospital, Thessaloniki. History. 5 4 year old male with symptoms of weight loss abdominal pain Past medical history: colitis? for the last 3 years No family history of note. - PowerPoint PPT Presentation

Citation preview

Page 1: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Unit of Gastrenterology

Unit of Endocrinology

THEAGENIO Hospital, Thessaloniki

Metastatic neuroendocrine tumor of the jejunum-ileum

Page 2: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

54 year old male with symptoms of weight lossabdominal pain

Past medical history: colitis? for the last 3 yearsNo family history of note

History

Page 3: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Biochemistry-Radiology

Mildly raised LFT’s

Abdominal computed tomography (CT)3 cm mesenteric mass and liver lesion in segment IV

Page 4: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Surgical treatment (1)

The patient was referred for surgical treatment

and underwent (4/2008) laparotomy in which

a 4 cm segment of small bowel was excised along with 2 para-aortic lymph nodes

Page 5: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Histology

Carcinoid tumor of the small bowel, diameter 1.2 cm,invasive of all intestinal wall, with +2/2 lymph nodes

(+) CgA, NSEKi-67< 2% < 2 mitoses/10HPF

G1

The patient was referred to the Gastroenterology Unit

Page 6: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Clinical examination-Initial assessment

Weight: 55 kg, ΒΜΙ: 17 kg/m2

BP 110/70 mm HgClinical examination: nil of noteNo symptoms of carcinoid syndrome

CgA : 230 nmol/l (<4) , 24-h urine 5 HIIA: 1 mg (<8)Heart echo- : normal Οctreoscan: normal distribution

Page 7: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Medical treatment

Somatostatin analogues

Chemotherapy (SZT + 5FU) from 6/2008 (5

cycles)

Page 8: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Reassesment

Abdominal CT (12/2008)Multiple liver metastatic lesions 1-4 cm and a4 cm mass in front of aorta

Platinum based chemotherapy started 1/2009 (6 cycles)

Somatostatin analogues continued

During 2009 the disease remained radiologically stable, although CgA rose to 900 nmol/l

Page 9: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Initiation of mTOR inhibitors (2010)

From January 2010 and for 16 months the patient was treated with Everolimus 10 mg daily

Abdominal CT: Improvement of the large liver lesion by 20%

CgA substantially reduced to 250 nmol/l

The patient opted to stop treatment in May 2011

Page 10: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Οctreoscan (5/2011)

Uptake in some liver mets and abdomen

Page 11: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

At the beginning of 2012…

The patient was admitted at the hospital with severe epigastric pain and vomiting

Βarium follow-through

Gastroscopy

Stenosis of the 2nd part of duodenum

Page 12: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Abdominal CT (2/2012)

Page 13: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Abdominal CT (2/2012)

Page 14: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Surgical treatment (2)

Gastro-entero-anastomosis (3/2012)

Liver biopsy

Page 15: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

11 months later:

The patient was admitted again with symptoms of ileus

Cachexia, anemia, low albumin, increased PT

Dysfunction of the gastro-entero-anastomosis

Page 16: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Surgical treatment (3)

To the operating room for the 3rd time (3/2013)

A month later the patient succumbed to his disease

Page 17: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

In summary

This was a patient with midgut NET who developed

LN, hepatic and mesenteric metastases,

received treatment withSurgery (x 3)Somatostatin analoguesChemotherapyM-TOR inhibitors

and died 5 years after the initial diagnosis

Page 18: Unit of Gastrenterology  Unit of Endocrinology THEAGENIO Hospital, Thessaloniki

Points for discussion

Extent of initial surgical treatment (extensive vs conservative)

Repeated surgery (palliative)

Use of chemotherapy

Alternative therapeutic approaches